SlideShare uma empresa Scribd logo
1 de 45
Spirometry In
Children
Waheed Shouman
Chest Professor, Zagazig University
 The examination of lung function in
children is not easy .
 There is no gold standard method to
monitor pulmonary function in children
below 6 years
 The assessment of lung function in infants
and younger children is more challenging
and it is usually not included in routine
clinical examinations as it may require
sedation
•According to ATS and the ERS it would not be ethically
acceptable to sedate preschool children for pulmonary
function testing
Indications of PFT in children:
(1) Detection and identification of lung
disease (diagnosis)
(2) Assessment of disease progress
(disease monitoring and staging) and
(3) Analysis of therapy effectiveness
(therapy monitoring and optimization)
No child will cooperate with any
test if they feel threatened
intimidated
PFT that can be done in Children:
•Spirometry
•Plethysmograthy (Box)
•Impulse Oscillometry (IOS)
•Interruption Technique
•Gas Washout test (single or multiple breath)
•Hypoxia Challege Test
•Respiratory Inductive Plethysmography
•Electric Inductive Tomography
•Forced Deflation Technique (neonates and below 2 years)
•Fe No
•Eosophageal and Gastric Manometry
•Others,
Spirometry
Spirometry:
•“the measuring of breath”
•Spirometry is the basic examination in
lung function testing
•Spirometry is an established method to
study lung function in children
Reasons to perform spirometry in a
pediatric patient:
•To establish whether pulmonary mechanics are normal in a child with
symptoms.
•To define the nature and severity of any pulmonary dysfunction
(obstructive vs restrictive defect).
•To define the site of airway obstruction—central vs peripheral or
intrathoracic vs extrathoracic.
•To follow the course of pulmonary disease or assess the effect of
therapy.
•To establish the presence or absence of airway reactivity.
•To assess the risks of diagnostic or therapeutic procedures.
•To monitor for adverse effects of chemotherapy or radiation therapy.
•To predict prognosis or assess disability and to assess the effect of
disease on lung growth.
• Spirometry is a good measure of
obstructive lung disese in children
• It underestimate peripheral airway disese
• It can help to assess BHR, BDR
Contraindications for spirometry:
•No ABSOLUTE contraindications
•Some conditions may have a relative danger to a
patient or affect the validity of spirometry
performance and results.
Relative contraindications for
Spirometry:
•Hemoptysis of unknown origin
•Recent pneumothorax
•Thoracic, abdominal, or cerebral aneurysms
•Recent thoracic, abdominal or eye surgery
•Acute disorders such as nausea or vomiting
•Severe respiratory distress
•Physical limitations
•Cognitive impairment, dementia
•Inability to adequately understand and follow instructions
(except when familiarising child with spirometry)
 Spirometry in pre-school children has repeatedly
shown high failure rates, especially when
performing maximum expiratory flow volume
(MEFV) manoeuvres
 It was attributed to lack of coordination and poor
attention
• 95% of 8- to 9-year-old children were able to yield
adequate data
• From the age of six, children are usually able to
undergo the same examinations as adults
• Typically a child around 5 years old will have a
50% chance of performing spirometry adequately
in a child orientated lab
• Some children aged 3–5 are able to achieve
reproducible efforts if the standard (adult)
guidelines are modified
Individuals interested in obtaining
spirometric results in young subjects
must be prepared to devote financial
resources to equipment and well-trained
technicians who are given adequate time
to work with the children
ATS/ERS recommend:
1.Development of reference equations that can cross from
preschool- into school-age children
2.Investigation of the utility of shorter timed expiratory
volumes (e.g., FEV0.5)
3. Development of software that automatically identifies
maneuvers that may not meet these quality-control
criteria,and which better assesses end of test in very young
children
ATS/ERS recommend:
4. Assessing both short- and long-term variability of these
spirometric maneuvers in the preschool-aged child
5. Defining bronchodilator response in the individual child
6. Assessing the clinical applicability of this technique in
various disease states
ATS/ERS recommend:
1.Reference values from adults should not be extrapolated for children
less than 6 years old Testing children in “adult” laboratories requires
extra time and effort
2.The validity of the selected reference data for use in those with
respiratory disease should be checked by studying at least 30 to 50
healthy preschool children using identical techniques and comparing
their results with those of the similar reference population (same age,
body size, sex, and ethnic group)
3. Results should, by preference, be expressed as z scores (i.e., multiples
of the standard deviation [SD] from the mean) and not as percentages of
predicted values
4.Variability measurements should not be extrapolated from healthy
children to those with disease. Within-subject variability (within and
between occasions) assessments need to be made in at least 30
(preferably more) subjects of similar age and diagnostic category
Performing Spirometry
The quality of the findings obtained by pulmonary
function testing in infants and children is very much
dependent on the person performing the test
Only fully dedicated investigators guarantee good
quality and reproducible results
The children need to be trained and motivated
Experienced and patient personnel are required to
fulfil this task.
Factors affecting spirometry
in children:
•Height
•Age
•Sex
•Environmental factors
•Weight
•Ethnicity
•Prematurity
•Patient cooperation
•Effort and technical factors
• Height is the most important predictive
variable for lung function, followed by race
• Height measurement should be performed
at the time of spirometry.
• For nonambulatory patients, arm span can
be used to estimate height
If a child refused to
perform the spirometry:
•Ask parenets to do it in front of him
•If refused or can't, Praise and reward and re-
book
•Next time: Most children will be happy to
participate as they know that they will be
rewarded
• The nose is often covered with a
nose clip, they will breathy orally
in simple way than adults.
• The child must not wear clothing
that restricts chest movements.
• Feet must be on ground, whether
they are sitting or standing.
• Appropriate repeatability is defined as at
least two acceptable curves, with the
second highest FVC and FEV1 within 0.1 L
or 10% of the highest value, whichever is
greater
• Loops need to be rejected if they are less
than 0.5 s in duration, as no FEVt can be
reported
• Young children have small absolute lung volumes
and large airway size relative to lung volume
compared with older children and adults.
• American Thoracic Society criteria for acceptable
spirometry call for a 3-second exhalation in
children (6 seconds for adults and older children)
• Forced expiration is completed in a shorter time,
certainly more quickly than the 6 seconds
recommended for adults, but sometimes more
quickly than 1 second
• Minimum of three manoeuvres should be
recorded as in adults, but pre-school children
may undertake 10 or more attempts without
exhaustion until they achieve perfect technique
and an acceptable spirometric recording
• FEV0.75 and FEV0.5 have been used. In children
aged 6 years or younger, FEV0.75 was found to
provide information similar to that of FEV1
• The best loop is that with the highest sum
of FVC and FEV0.5 [as FEV0.5 is the
commonest FEVt to be recorded in children
less than 6 years.
• The flows MEF25, MEF50, MEF75 and MMEF,
are taken from the best loop.
• The highest values for FEV0.5, FEV0.75,
FEV1 and FVC are taken from any of the
technically acceptable loops
PEF
•PEF is a simple but very rough control measure
used in follow-up of respiratory diseases, above all
in asthma
•There is good evidence that routine home
monitoring of peak flow in each asthmatic child is
not justified and not useful
• PEF measured by a peak flow meter rather than by
a spirometer is inaccurate and overestimated in
the range of 200–400L/min
• When available, spirometers should be preferred
to peak flow meters for measuring lung function in
children.
• Studying FEV1, FEV1/FVC, and FEF25-75 in
children with asthma, it was found that FEF25-75
is a more sensitive indicator of airway obstruction.
FEV1:
•It can not be obtained in very young children
•No evidence that it help in asthma control
•Values above 80% of predicted are
considered normal
FEV1/FVC:
•Though the FEV1/FVC ratio is considered a
valuable indicator when assessing obstructive
airway disease, pre-school children have reported
ratios of FEV1/FVC as high as 90 to 95%
•The higher elastic recoil and more rapid emptying
of the lungs in the pediatric population can also lead
to a higher FEV1/FVC ratio
• FEV1/FVC ratio >80% is considered normal results
FVC and RV:
There is insufficient evidence to recommend
monitoring in clinical practice
Reversibility:
•ATS/ERS standards for interpretation suggest a minimal
change for significance is a 12% increase in FEV1 or FVC,
with a minimal absolute change of 200 mL. There is no
reference to children; 200 mL represents a much larger
relative volume in a small child than in an adult
•There are no national or international guidelines specific to
children for the interpretation of BDR, 10% was suggested in
one longitudinal study and FEF25% –75% by 20% to 30%
Longitudinal studies for same
child:
A minimum change from baseline for significance
has been defined by some as ±10% for FVC and
FEV1, and ±25% for FEF 25%-75%
Thank You

Mais conteúdo relacionado

Mais procurados

HIGH FREQUENCY VENTILATION - NEONATES
HIGH FREQUENCY VENTILATION - NEONATESHIGH FREQUENCY VENTILATION - NEONATES
HIGH FREQUENCY VENTILATION - NEONATESAdhi Arya
 
Approach to Respiratory Distress in Children By Essam Sidqi
Approach to Respiratory Distress in Children By Essam SidqiApproach to Respiratory Distress in Children By Essam Sidqi
Approach to Respiratory Distress in Children By Essam SidqiEssam Sidqi Yaqoob
 
Interpretation OF PFT
Interpretation OF PFT		Interpretation OF PFT
Interpretation OF PFT Khalid
 
Pulmonary Function Test ppt
Pulmonary Function Test pptPulmonary Function Test ppt
Pulmonary Function Test pptIfra Khan
 
Broncho provocation testing ppt
Broncho provocation testing pptBroncho provocation testing ppt
Broncho provocation testing pptWaseem MD abdul
 
HFOV - High Frequency Oscillatory Ventilation
HFOV - High Frequency Oscillatory VentilationHFOV - High Frequency Oscillatory Ventilation
HFOV - High Frequency Oscillatory VentilationNaveen Kumar Cheri
 
Mechanical ventilation in neonates
Mechanical ventilation in neonatesMechanical ventilation in neonates
Mechanical ventilation in neonatespune2013
 
Pediatric Acute Respiratory Distress Syndrome
Pediatric Acute Respiratory Distress Syndrome Pediatric Acute Respiratory Distress Syndrome
Pediatric Acute Respiratory Distress Syndrome Owais Mohd
 
Reactive airway obstruction in children detection management_2018_pmm
Reactive airway obstruction  in children detection management_2018_pmmReactive airway obstruction  in children detection management_2018_pmm
Reactive airway obstruction in children detection management_2018_pmmParthiv Mehta
 
High Frequency Oscillatory Ventilation
High Frequency Oscillatory VentilationHigh Frequency Oscillatory Ventilation
High Frequency Oscillatory VentilationMuhammad Asim Rana
 
Persistent pulmonary hypertension(pphn)
Persistent pulmonary hypertension(pphn) Persistent pulmonary hypertension(pphn)
Persistent pulmonary hypertension(pphn) gilyjacob
 
Pphn in neonates: Updates on management
Pphn in neonates: Updates on managementPphn in neonates: Updates on management
Pphn in neonates: Updates on managementSujit Shrestha
 
Wheezy chest in pediatrics
Wheezy chest in pediatrics Wheezy chest in pediatrics
Wheezy chest in pediatrics danielrawand
 

Mais procurados (20)

HIGH FREQUENCY VENTILATION - NEONATES
HIGH FREQUENCY VENTILATION - NEONATESHIGH FREQUENCY VENTILATION - NEONATES
HIGH FREQUENCY VENTILATION - NEONATES
 
Approach to Respiratory Distress in Children By Essam Sidqi
Approach to Respiratory Distress in Children By Essam SidqiApproach to Respiratory Distress in Children By Essam Sidqi
Approach to Respiratory Distress in Children By Essam Sidqi
 
Respiratory failure ped
Respiratory failure pedRespiratory failure ped
Respiratory failure ped
 
Surfactant therapy
Surfactant therapySurfactant therapy
Surfactant therapy
 
Neonatal Ventilation
Neonatal VentilationNeonatal Ventilation
Neonatal Ventilation
 
Pphn
PphnPphn
Pphn
 
Pulmonary function tests
Pulmonary function testsPulmonary function tests
Pulmonary function tests
 
Interpretation OF PFT
Interpretation OF PFT		Interpretation OF PFT
Interpretation OF PFT
 
Pulmonary Function Test ppt
Pulmonary Function Test pptPulmonary Function Test ppt
Pulmonary Function Test ppt
 
Broncho provocation testing ppt
Broncho provocation testing pptBroncho provocation testing ppt
Broncho provocation testing ppt
 
HFOV - High Frequency Oscillatory Ventilation
HFOV - High Frequency Oscillatory VentilationHFOV - High Frequency Oscillatory Ventilation
HFOV - High Frequency Oscillatory Ventilation
 
Chapter 1 fetal lung development
Chapter 1 fetal lung developmentChapter 1 fetal lung development
Chapter 1 fetal lung development
 
Mechanical ventilation in neonates
Mechanical ventilation in neonatesMechanical ventilation in neonates
Mechanical ventilation in neonates
 
T piece resuscitator
T piece resuscitatorT piece resuscitator
T piece resuscitator
 
Pediatric Acute Respiratory Distress Syndrome
Pediatric Acute Respiratory Distress Syndrome Pediatric Acute Respiratory Distress Syndrome
Pediatric Acute Respiratory Distress Syndrome
 
Reactive airway obstruction in children detection management_2018_pmm
Reactive airway obstruction  in children detection management_2018_pmmReactive airway obstruction  in children detection management_2018_pmm
Reactive airway obstruction in children detection management_2018_pmm
 
High Frequency Oscillatory Ventilation
High Frequency Oscillatory VentilationHigh Frequency Oscillatory Ventilation
High Frequency Oscillatory Ventilation
 
Persistent pulmonary hypertension(pphn)
Persistent pulmonary hypertension(pphn) Persistent pulmonary hypertension(pphn)
Persistent pulmonary hypertension(pphn)
 
Pphn in neonates: Updates on management
Pphn in neonates: Updates on managementPphn in neonates: Updates on management
Pphn in neonates: Updates on management
 
Wheezy chest in pediatrics
Wheezy chest in pediatrics Wheezy chest in pediatrics
Wheezy chest in pediatrics
 

Semelhante a Spirometry in children

Pediatric Asthma.pptx
Pediatric Asthma.pptxPediatric Asthma.pptx
Pediatric Asthma.pptxAbbyMwaniki
 
Pulmonary function tests by Ismat bano
Pulmonary function tests by Ismat banoPulmonary function tests by Ismat bano
Pulmonary function tests by Ismat banoPARUL UNIVERSITY
 
Aneasthesia 2 year (2)
Aneasthesia    2 year (2)Aneasthesia    2 year (2)
Aneasthesia 2 year (2)gishabay
 
8.had and tb
8.had and tb8.had and tb
8.had and tbgishabay
 
What 2012 lung function ultrasound physiology
What 2012 lung function ultrasound physiologyWhat 2012 lung function ultrasound physiology
What 2012 lung function ultrasound physiologyEnvicon Medical Srl
 
Acute_respiratory_diseses_in_Children___Croup.pptx
Acute_respiratory_diseses_in_Children___Croup.pptxAcute_respiratory_diseses_in_Children___Croup.pptx
Acute_respiratory_diseses_in_Children___Croup.pptxesicOrtho1
 
bronchialasthma in children treatment.pptx
bronchialasthma in children treatment.pptxbronchialasthma in children treatment.pptx
bronchialasthma in children treatment.pptxssuser90ffff
 
Weaning from mechanical ventilation and extubation by dr tareq
Weaning from mechanical ventilation and extubation by dr tareqWeaning from mechanical ventilation and extubation by dr tareq
Weaning from mechanical ventilation and extubation by dr tareqtareq rahman
 
Osa in children by DR shashidhar tatavarthy
Osa in children by DR shashidhar tatavarthyOsa in children by DR shashidhar tatavarthy
Osa in children by DR shashidhar tatavarthySHASHIDHAR T B
 
Reactive airway diseases_2018_pmm
Reactive airway diseases_2018_pmmReactive airway diseases_2018_pmm
Reactive airway diseases_2018_pmmParthiv Mehta
 
Brief resolved unexplained events (brue)
Brief resolved unexplained events (brue)Brief resolved unexplained events (brue)
Brief resolved unexplained events (brue)Mohammad ALktifan
 
Cohort design by Dr Amita Kashyap Prof PSM
Cohort design  by Dr Amita Kashyap Prof PSMCohort design  by Dr Amita Kashyap Prof PSM
Cohort design by Dr Amita Kashyap Prof PSMamitakashyap1
 

Semelhante a Spirometry in children (20)

Bronchial Asthama
Bronchial Asthama Bronchial Asthama
Bronchial Asthama
 
Pediatric Asthma.pptx
Pediatric Asthma.pptxPediatric Asthma.pptx
Pediatric Asthma.pptx
 
Pulmonary function tests by Ismat bano
Pulmonary function tests by Ismat banoPulmonary function tests by Ismat bano
Pulmonary function tests by Ismat bano
 
Aneasthesia 2 year (2)
Aneasthesia    2 year (2)Aneasthesia    2 year (2)
Aneasthesia 2 year (2)
 
8.had and tb
8.had and tb8.had and tb
8.had and tb
 
Childhood asthma & TB
Childhood asthma & TBChildhood asthma & TB
Childhood asthma & TB
 
hfnc final.pptx
hfnc final.pptxhfnc final.pptx
hfnc final.pptx
 
Apparent life threatening event
Apparent life threatening eventApparent life threatening event
Apparent life threatening event
 
What 2012 lung function ultrasound physiology
What 2012 lung function ultrasound physiologyWhat 2012 lung function ultrasound physiology
What 2012 lung function ultrasound physiology
 
Acute_respiratory_diseses_in_Children___Croup.pptx
Acute_respiratory_diseses_in_Children___Croup.pptxAcute_respiratory_diseses_in_Children___Croup.pptx
Acute_respiratory_diseses_in_Children___Croup.pptx
 
bronchialasthma in children treatment.pptx
bronchialasthma in children treatment.pptxbronchialasthma in children treatment.pptx
bronchialasthma in children treatment.pptx
 
Management of chronic asthma Pediatrics
Management of chronic asthma PediatricsManagement of chronic asthma Pediatrics
Management of chronic asthma Pediatrics
 
Weaning from mechanical ventilation and extubation by dr tareq
Weaning from mechanical ventilation and extubation by dr tareqWeaning from mechanical ventilation and extubation by dr tareq
Weaning from mechanical ventilation and extubation by dr tareq
 
Osa in children by DR shashidhar tatavarthy
Osa in children by DR shashidhar tatavarthyOsa in children by DR shashidhar tatavarthy
Osa in children by DR shashidhar tatavarthy
 
PULMONARY FUNCTION TEST(PFT).pptx
PULMONARY FUNCTION TEST(PFT).pptxPULMONARY FUNCTION TEST(PFT).pptx
PULMONARY FUNCTION TEST(PFT).pptx
 
Pulmonary function test and bronchial challenge test
Pulmonary function test and bronchial challenge testPulmonary function test and bronchial challenge test
Pulmonary function test and bronchial challenge test
 
Reactive airway diseases_2018_pmm
Reactive airway diseases_2018_pmmReactive airway diseases_2018_pmm
Reactive airway diseases_2018_pmm
 
Seminar ari
Seminar ariSeminar ari
Seminar ari
 
Brief resolved unexplained events (brue)
Brief resolved unexplained events (brue)Brief resolved unexplained events (brue)
Brief resolved unexplained events (brue)
 
Cohort design by Dr Amita Kashyap Prof PSM
Cohort design  by Dr Amita Kashyap Prof PSMCohort design  by Dr Amita Kashyap Prof PSM
Cohort design by Dr Amita Kashyap Prof PSM
 

Mais de Waheed Shouman

Future Of COPD Treatment Short.pptx
Future Of COPD Treatment Short.pptxFuture Of COPD Treatment Short.pptx
Future Of COPD Treatment Short.pptxWaheed Shouman
 
Waheed Shouman covid-19 chronic lung diseases
Waheed Shouman covid-19 chronic lung diseasesWaheed Shouman covid-19 chronic lung diseases
Waheed Shouman covid-19 chronic lung diseasesWaheed Shouman
 
Covid-19 and time 10 7-2020
Covid-19 and time 10 7-2020Covid-19 and time 10 7-2020
Covid-19 and time 10 7-2020Waheed Shouman
 
Covid 19 management 6 months later
Covid 19 management 6 months laterCovid 19 management 6 months later
Covid 19 management 6 months laterWaheed Shouman
 
Weaning From Mechanical Ventilation
Weaning From Mechanical VentilationWeaning From Mechanical Ventilation
Weaning From Mechanical VentilationWaheed Shouman
 
Indications and Modes of Mechanical Ventilation
Indications and Modes of Mechanical VentilationIndications and Modes of Mechanical Ventilation
Indications and Modes of Mechanical VentilationWaheed Shouman
 
Nonconventional Drugs for Acute Severe Asthma
Nonconventional Drugs for Acute Severe AsthmaNonconventional Drugs for Acute Severe Asthma
Nonconventional Drugs for Acute Severe AsthmaWaheed Shouman
 
Cancer in vein 2 11-2018
Cancer in vein 2 11-2018Cancer in vein 2 11-2018
Cancer in vein 2 11-2018Waheed Shouman
 
Git in mv patients 3 5-18
Git in mv patients 3 5-18Git in mv patients 3 5-18
Git in mv patients 3 5-18Waheed Shouman
 
NIV in Acute Respiratory Failure
NIV in Acute Respiratory FailureNIV in Acute Respiratory Failure
NIV in Acute Respiratory FailureWaheed Shouman
 
Mechanical ventilation and stroke
Mechanical ventilation and strokeMechanical ventilation and stroke
Mechanical ventilation and strokeWaheed Shouman
 
Psychiatric aspects of common lung diseases
Psychiatric aspects of common lung diseasesPsychiatric aspects of common lung diseases
Psychiatric aspects of common lung diseasesWaheed Shouman
 
Copd systemic inflammation or systemic manifestations
Copd systemic inflammation or systemic manifestationsCopd systemic inflammation or systemic manifestations
Copd systemic inflammation or systemic manifestationsWaheed Shouman
 
Asthma on the machine 27 5-2015
Asthma on the machine 27 5-2015Asthma on the machine 27 5-2015
Asthma on the machine 27 5-2015Waheed Shouman
 
Pulmonary overlaps in icu
Pulmonary overlaps in icuPulmonary overlaps in icu
Pulmonary overlaps in icuWaheed Shouman
 
Women fingerprints in medicine....... Landmark Women in History of Medicine
Women fingerprints in medicine....... Landmark Women in History of MedicineWomen fingerprints in medicine....... Landmark Women in History of Medicine
Women fingerprints in medicine....... Landmark Women in History of MedicineWaheed Shouman
 
Future directions in copd management
Future directions in copd managementFuture directions in copd management
Future directions in copd managementWaheed Shouman
 

Mais de Waheed Shouman (20)

Future Of COPD Treatment Short.pptx
Future Of COPD Treatment Short.pptxFuture Of COPD Treatment Short.pptx
Future Of COPD Treatment Short.pptx
 
Waheed Shouman covid-19 chronic lung diseases
Waheed Shouman covid-19 chronic lung diseasesWaheed Shouman covid-19 chronic lung diseases
Waheed Shouman covid-19 chronic lung diseases
 
Covid-19 and time 10 7-2020
Covid-19 and time 10 7-2020Covid-19 and time 10 7-2020
Covid-19 and time 10 7-2020
 
Covid 19 management 6 months later
Covid 19 management 6 months laterCovid 19 management 6 months later
Covid 19 management 6 months later
 
Covid 19
Covid 19 Covid 19
Covid 19
 
Weaning From Mechanical Ventilation
Weaning From Mechanical VentilationWeaning From Mechanical Ventilation
Weaning From Mechanical Ventilation
 
Update in CAP 2019
Update in CAP 2019Update in CAP 2019
Update in CAP 2019
 
Indications and Modes of Mechanical Ventilation
Indications and Modes of Mechanical VentilationIndications and Modes of Mechanical Ventilation
Indications and Modes of Mechanical Ventilation
 
Nonconventional Drugs for Acute Severe Asthma
Nonconventional Drugs for Acute Severe AsthmaNonconventional Drugs for Acute Severe Asthma
Nonconventional Drugs for Acute Severe Asthma
 
Cancer in vein 2 11-2018
Cancer in vein 2 11-2018Cancer in vein 2 11-2018
Cancer in vein 2 11-2018
 
Git in mv patients 3 5-18
Git in mv patients 3 5-18Git in mv patients 3 5-18
Git in mv patients 3 5-18
 
HFNC
HFNCHFNC
HFNC
 
NIV in Acute Respiratory Failure
NIV in Acute Respiratory FailureNIV in Acute Respiratory Failure
NIV in Acute Respiratory Failure
 
Mechanical ventilation and stroke
Mechanical ventilation and strokeMechanical ventilation and stroke
Mechanical ventilation and stroke
 
Psychiatric aspects of common lung diseases
Psychiatric aspects of common lung diseasesPsychiatric aspects of common lung diseases
Psychiatric aspects of common lung diseases
 
Copd systemic inflammation or systemic manifestations
Copd systemic inflammation or systemic manifestationsCopd systemic inflammation or systemic manifestations
Copd systemic inflammation or systemic manifestations
 
Asthma on the machine 27 5-2015
Asthma on the machine 27 5-2015Asthma on the machine 27 5-2015
Asthma on the machine 27 5-2015
 
Pulmonary overlaps in icu
Pulmonary overlaps in icuPulmonary overlaps in icu
Pulmonary overlaps in icu
 
Women fingerprints in medicine....... Landmark Women in History of Medicine
Women fingerprints in medicine....... Landmark Women in History of MedicineWomen fingerprints in medicine....... Landmark Women in History of Medicine
Women fingerprints in medicine....... Landmark Women in History of Medicine
 
Future directions in copd management
Future directions in copd managementFuture directions in copd management
Future directions in copd management
 

Último

Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 

Último (20)

Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 

Spirometry in children

  • 1. Spirometry In Children Waheed Shouman Chest Professor, Zagazig University
  • 2.  The examination of lung function in children is not easy .  There is no gold standard method to monitor pulmonary function in children below 6 years  The assessment of lung function in infants and younger children is more challenging and it is usually not included in routine clinical examinations as it may require sedation
  • 3. •According to ATS and the ERS it would not be ethically acceptable to sedate preschool children for pulmonary function testing
  • 4. Indications of PFT in children: (1) Detection and identification of lung disease (diagnosis) (2) Assessment of disease progress (disease monitoring and staging) and (3) Analysis of therapy effectiveness (therapy monitoring and optimization)
  • 5. No child will cooperate with any test if they feel threatened intimidated
  • 6. PFT that can be done in Children: •Spirometry •Plethysmograthy (Box) •Impulse Oscillometry (IOS) •Interruption Technique •Gas Washout test (single or multiple breath) •Hypoxia Challege Test •Respiratory Inductive Plethysmography •Electric Inductive Tomography •Forced Deflation Technique (neonates and below 2 years) •Fe No •Eosophageal and Gastric Manometry •Others,
  • 7.
  • 9. Spirometry: •“the measuring of breath” •Spirometry is the basic examination in lung function testing •Spirometry is an established method to study lung function in children
  • 10.
  • 11. Reasons to perform spirometry in a pediatric patient: •To establish whether pulmonary mechanics are normal in a child with symptoms. •To define the nature and severity of any pulmonary dysfunction (obstructive vs restrictive defect). •To define the site of airway obstruction—central vs peripheral or intrathoracic vs extrathoracic. •To follow the course of pulmonary disease or assess the effect of therapy. •To establish the presence or absence of airway reactivity. •To assess the risks of diagnostic or therapeutic procedures. •To monitor for adverse effects of chemotherapy or radiation therapy. •To predict prognosis or assess disability and to assess the effect of disease on lung growth.
  • 12.
  • 13. • Spirometry is a good measure of obstructive lung disese in children • It underestimate peripheral airway disese • It can help to assess BHR, BDR
  • 14. Contraindications for spirometry: •No ABSOLUTE contraindications •Some conditions may have a relative danger to a patient or affect the validity of spirometry performance and results.
  • 15. Relative contraindications for Spirometry: •Hemoptysis of unknown origin •Recent pneumothorax •Thoracic, abdominal, or cerebral aneurysms •Recent thoracic, abdominal or eye surgery •Acute disorders such as nausea or vomiting •Severe respiratory distress •Physical limitations •Cognitive impairment, dementia •Inability to adequately understand and follow instructions (except when familiarising child with spirometry)
  • 16.  Spirometry in pre-school children has repeatedly shown high failure rates, especially when performing maximum expiratory flow volume (MEFV) manoeuvres  It was attributed to lack of coordination and poor attention
  • 17. • 95% of 8- to 9-year-old children were able to yield adequate data • From the age of six, children are usually able to undergo the same examinations as adults • Typically a child around 5 years old will have a 50% chance of performing spirometry adequately in a child orientated lab • Some children aged 3–5 are able to achieve reproducible efforts if the standard (adult) guidelines are modified
  • 18. Individuals interested in obtaining spirometric results in young subjects must be prepared to devote financial resources to equipment and well-trained technicians who are given adequate time to work with the children
  • 19. ATS/ERS recommend: 1.Development of reference equations that can cross from preschool- into school-age children 2.Investigation of the utility of shorter timed expiratory volumes (e.g., FEV0.5) 3. Development of software that automatically identifies maneuvers that may not meet these quality-control criteria,and which better assesses end of test in very young children
  • 20. ATS/ERS recommend: 4. Assessing both short- and long-term variability of these spirometric maneuvers in the preschool-aged child 5. Defining bronchodilator response in the individual child 6. Assessing the clinical applicability of this technique in various disease states
  • 21. ATS/ERS recommend: 1.Reference values from adults should not be extrapolated for children less than 6 years old Testing children in “adult” laboratories requires extra time and effort 2.The validity of the selected reference data for use in those with respiratory disease should be checked by studying at least 30 to 50 healthy preschool children using identical techniques and comparing their results with those of the similar reference population (same age, body size, sex, and ethnic group) 3. Results should, by preference, be expressed as z scores (i.e., multiples of the standard deviation [SD] from the mean) and not as percentages of predicted values 4.Variability measurements should not be extrapolated from healthy children to those with disease. Within-subject variability (within and between occasions) assessments need to be made in at least 30 (preferably more) subjects of similar age and diagnostic category
  • 22.
  • 23.
  • 24.
  • 26. The quality of the findings obtained by pulmonary function testing in infants and children is very much dependent on the person performing the test Only fully dedicated investigators guarantee good quality and reproducible results The children need to be trained and motivated Experienced and patient personnel are required to fulfil this task.
  • 27. Factors affecting spirometry in children: •Height •Age •Sex •Environmental factors •Weight •Ethnicity •Prematurity •Patient cooperation •Effort and technical factors
  • 28. • Height is the most important predictive variable for lung function, followed by race • Height measurement should be performed at the time of spirometry. • For nonambulatory patients, arm span can be used to estimate height
  • 29.
  • 30. If a child refused to perform the spirometry: •Ask parenets to do it in front of him •If refused or can't, Praise and reward and re- book •Next time: Most children will be happy to participate as they know that they will be rewarded
  • 31. • The nose is often covered with a nose clip, they will breathy orally in simple way than adults. • The child must not wear clothing that restricts chest movements. • Feet must be on ground, whether they are sitting or standing.
  • 32. • Appropriate repeatability is defined as at least two acceptable curves, with the second highest FVC and FEV1 within 0.1 L or 10% of the highest value, whichever is greater • Loops need to be rejected if they are less than 0.5 s in duration, as no FEVt can be reported
  • 33. • Young children have small absolute lung volumes and large airway size relative to lung volume compared with older children and adults. • American Thoracic Society criteria for acceptable spirometry call for a 3-second exhalation in children (6 seconds for adults and older children) • Forced expiration is completed in a shorter time, certainly more quickly than the 6 seconds recommended for adults, but sometimes more quickly than 1 second
  • 34. • Minimum of three manoeuvres should be recorded as in adults, but pre-school children may undertake 10 or more attempts without exhaustion until they achieve perfect technique and an acceptable spirometric recording • FEV0.75 and FEV0.5 have been used. In children aged 6 years or younger, FEV0.75 was found to provide information similar to that of FEV1
  • 35.
  • 36.
  • 37. • The best loop is that with the highest sum of FVC and FEV0.5 [as FEV0.5 is the commonest FEVt to be recorded in children less than 6 years. • The flows MEF25, MEF50, MEF75 and MMEF, are taken from the best loop. • The highest values for FEV0.5, FEV0.75, FEV1 and FVC are taken from any of the technically acceptable loops
  • 38. PEF •PEF is a simple but very rough control measure used in follow-up of respiratory diseases, above all in asthma •There is good evidence that routine home monitoring of peak flow in each asthmatic child is not justified and not useful
  • 39. • PEF measured by a peak flow meter rather than by a spirometer is inaccurate and overestimated in the range of 200–400L/min • When available, spirometers should be preferred to peak flow meters for measuring lung function in children. • Studying FEV1, FEV1/FVC, and FEF25-75 in children with asthma, it was found that FEF25-75 is a more sensitive indicator of airway obstruction.
  • 40. FEV1: •It can not be obtained in very young children •No evidence that it help in asthma control •Values above 80% of predicted are considered normal
  • 41. FEV1/FVC: •Though the FEV1/FVC ratio is considered a valuable indicator when assessing obstructive airway disease, pre-school children have reported ratios of FEV1/FVC as high as 90 to 95% •The higher elastic recoil and more rapid emptying of the lungs in the pediatric population can also lead to a higher FEV1/FVC ratio • FEV1/FVC ratio >80% is considered normal results
  • 42. FVC and RV: There is insufficient evidence to recommend monitoring in clinical practice
  • 43. Reversibility: •ATS/ERS standards for interpretation suggest a minimal change for significance is a 12% increase in FEV1 or FVC, with a minimal absolute change of 200 mL. There is no reference to children; 200 mL represents a much larger relative volume in a small child than in an adult •There are no national or international guidelines specific to children for the interpretation of BDR, 10% was suggested in one longitudinal study and FEF25% –75% by 20% to 30%
  • 44. Longitudinal studies for same child: A minimum change from baseline for significance has been defined by some as ±10% for FVC and FEV1, and ±25% for FEF 25%-75%